Letter

Dissemination of results needs to be tracked as well as the funding is

BMJ 2005; 331 doi: 10.1136/bmj.331.7514.456-a (Published 18 August 2005)
Cite this as: BMJ 2005;331:456.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. James McCormack, professor (jmccorma@interchange.ubc.ca),
  2. Peter Loewen, associate professor, part time,
  3. Peter Jewesson, professor
  1. Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
  2. Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada

    EDITOR—Decullier et al evaluated some of the factors influencing publication of health related research projects.1 They examined research activity outcomes from the perspective of research ethics approval.

    Registration of clinical trials is not universally required, and sponsor databases are necessarily limited in scope. However, approval by a research ethics committee is required for all research on human subjects and includes protocols regardless of funding status and origin. …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular